Results 11 to 20 of about 3,193,785 (231)

Chronic Respiratory Disease Prevalence, Burden, and Treatment in Cape Town: A Cross-Sectional Study. [PDF]

Health Sci Rep
ABSTRACT Background and Aims There is a high burden of respiratory symptoms in South Africa, but accurate classification of diagnoses is challenging. Due to the adverse risk profile, inhaled corticosteroid (ICS) treatment should only be used in specific conditions, such as asthma or chronic obstructive pulmonary disease (COPD) with eosinophilia.
Stolbrink M, Liebenberg L, Ndlelana T, Petersen K, Griffith-Richards S, Mortimer K, Allwood B.   +6 more
europepmc   +2 more sources

Long-acting β2-adrenergic receptor agonist in pediatric asthma

Allergology International, 2004
Long-acting β2-adrenergic receptor agonists (LABA), a class of agents for the long-term management of childhood bronchial asthma, are recommended for use in combination with steroid inhalation for the treatment of the morning dip in severe childhood ...
Shigemi Yoshihara, Yumi Yamada, Toshio Abe, Osamu Arisaka   +3 more
doaj   +1 more source

Bronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness

Allergy, Asthma & Clinical Immunology, 2007
Anticholinergics, or specific antimuscarinic agents, by inhibition of muscarinic receptors cause bronchodilatation, which might correlate with activation of these receptors by the muscarinic agonist methacholine.
Petanjek Bojana B, Grle Sanja P, Pelicarić Dubravka, Vranković Dubravka   +3 more
doaj   +1 more source

Paediatrics: how to manage acute asthma exacerbations

Drugs in Context, 2021
Background: Asthma is the most common chronic disease of childhood and a major source of childhood health burden worldwide. These burdens are particularly marked when children experience characteristic ‘symptom flare-ups’ or acute asthma exacerbations ...
James S Leung
doaj   +1 more source

Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

BMC Pulmonary Medicine, 2018
Background In exacerbations of chronic obstructive pulmonary disease, administration of high concentrations of oxygen may cause hypercapnia and increase mortality compared with oxygen titrated, if required, to achieve an oxygen saturation of 88–92 ...
George Bardsley, Janine Pilcher, Steven McKinstry, Philippa Shirtcliffe, James Berry, James Fingleton, Mark Weatherall, Richard Beasley   +7 more
doaj   +1 more source

Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety

Therapeutic Advances in Respiratory Disease, 2015
The international guidelines on chronic obstructive pulmonary disease (COPD) recommend inhaled bronchodilators for maintenance treatment of the disease. These drugs include β2-agonists and muscarinic antagonists, which are both available as short-acting ...
Erminia Ridolo, Marcello Montagni, Gian Galeazzo Riario-Sforza, Marco Baroni, Cristoforo Incorvaia   +4 more
doaj   +1 more source

Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease

BMC Pulmonary Medicine, 2022
Background Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive and irreversible airflow limitation. Different factors that modify pulmonary function include age, sex, muscular strength, and a history of exposure to toxic agents ...
Nathalie Martínez-Luna, A. Orea-Tejeda, D. González-Islas, L. Flores-Cisneros, C. Keirns-Davis, R. Sánchez-Santillán, Ilse Pérez-García, Y. Gastelum-Ayala, Valeria Martínez-Vázquez, Ó. Martínez-Reyna   +9 more
semanticscholar   +1 more source

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation

Lung India, 2016
Context: The combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) is widely used in the treatment of moderate-to-severe asthma uncontrolled by ICS alone. Aims: To evaluate the efficacy and safety of a new ICS-LABA combination
Sundeep S Salvi, Abhijit J Vaidya, Rahul R Kodgule, Jaideep A Gogtay   +3 more
doaj   +1 more source

BRONCHIAL RESPONSE TIME TO A BRONCHODILATING AGENT-ORCIPRENALINE

The Keio Journal of Medicine, 1973
The specific airway conductance (Gaw/Vtg) of 4 normal subjects and 5 subjects with respiratory diseases was measured before and after inhalation of orciprenaline. There was an almost maximum increase in Gaw/Vtg within 3 to 4 minutes in both groups of subjects after inhalation of orciprenaline.
Jun Kagawa, Masamichi Tajika, Shizuo Katagiri   +2 more
openaire   +4 more sources

Beta-2 agonists for the treatment of bronchiolitis

Medwave, 2020
INTRODUCCIÓN La bronquiolitis es la inflamación aguda de las vías aéreas de pequeño calibre, teniendo como causa principal las infecciones virales. Es altamente frecuente en menores de dos años, sobretodo en menores de 12 meses. Existe gran controversia
Constanza Gómez, Gonzalo Alarcón, Lorena Cifuentes   +2 more
doaj   +1 more source